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With the rapid advances in stem cell research in recent years, a multitude of
musculoskeletal stem cells have been investigated in different contexts.
Several major musculoskeletal problems, such as fracture non-union, liga-
ment injury, as well as osteoporosis, may be benefited from stem cells. In
this workshop, we will focus on recent translational advances in the above
mentioned fields. Based on the above mentioned principles of tissue
regeneration, reconstructing segmental bone defects after resection of
malignant bone tumors, a long-standing challenge for orthopaedic surgeons,
was an excellent demonstration of the application of mesenchymal stem
cells (MSCs) in bone tissue engineering. With the increased knowledge of
MSCs, we have demonstrated that it is possible to reconstruct segmental
bone defects using a tissue engineering approach. Also, the combination of
nanotechnology with MSCs for skeletal regeneration is another good
example. We have cultured MSCs on biomimetic electrospun Type 1 collagen
nanofiber scaffold, making the composite an excellent advanced therapy
product for reconstruction of flat bones. Also investigation of mechanobi-
ology of MSCs in the context of three-dimensional interaction with porous
scaffolds with various spatial boundary conditions and stiffness will be
reported.
It is the clinical unmet need to search an osteoinductive agent and
combined use with osteoconductive bone substitutes for large bone defect
or delayed-union bone fracture. Other than growth factors, like BMP2 or
BMP7, the small molecule agents may be more beneficial for clinical appli-
cation because of their molecular stability and production cost. Among the
potential osteoinductive small molecules, simvastatin is of interest for my
research team. We fabricated the PLGA carrier to control the release con-
centration of simvastatin that covers the effective concentration range for
osteoinduction in bone marrow mesenchymal stem cells (BMSCs). The po-
tentials of simvastatin/PLGA as an osteoinductive agent for applying on
BMCs-based bone tissue engineering will be presented in this workshop.i.org/10.1016/j.jot.2016.06.017Also, in this workshop, we will focus on identify the general and regen-
erative properties of stem cells from soft tissues such as cruciate ligament
and synovial tissue. In our study, multipotent stem cells can be isolated and
expanded from human anterior cruciate ligament, posterior cruciate liga-
ment, and synovium of knee joint. Stem cells from these mesenchymal tis-
sues possess general stem cell properties such as single cells proliferation,
trilineage differentiation, and in vitro dividing for a long period, which are
identical with stem cells from bone marrow. However, stem cells from these
different mesenchymal tissues possess very different proliferation and dif-
ferentiation ability with different growth factor stimulation. These different
properties of stem cells with variable treatment and environment might
have great influence on the application of these mesenchymal stem cells in
regeneration of human soft tissue such as cruciate ligament, Achilles tendon
and collateral ligament.
In summary, stem cells from soft tissue are easily obtained from patients
during orthopaedic surgery. The proliferation and differentiation abilities of
these stem cells are greatly enhanced with appropriate cytokine treatment.
Self-renewal and mesodermal differentiation potential of these cells make
them a viable alternative cell source for use in regenerative medicine.SpeakersSpeaker 1: Clinical application and molecular mechanism
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